AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] American Electric Power Company, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Form 4 filed for NeuroOne Medical Technologies Corp. (NMTC) discloses a minor insider transaction by Chief Technology Officer Steve Mertens on 30 June 2025.

  • Transaction type: Code F, which reflects shares withheld to satisfy tax obligations.
  • Shares affected: 906 common shares at an indicated price of $0.678 per share.
  • Post-transaction holding: Mertens directly owns 162,235 NMTC common shares.
  • Derivative securities: None reported.

The filing represents routine tax-related share withholding and does not indicate open-market buying or selling. The magnitude�<1% of the executive’s reported holdings—is too small to materially affect ownership structure or signal a strategic shift.

Il modulo 4 presentato per NeuroOne Medical Technologies Corp. (NMTC) riporta una piccola transazione interna effettuata dal Chief Technology Officer Steve Mertens il 30 giugno 2025.

  • Tipo di transazione: Codice F, che indica azioni trattenute per soddisfare obblighi fiscali.
  • Azioni interessate: 906 azioni ordinarie a un prezzo indicato di $0,678 per azione.
  • Detenzione post-transazione: Mertens possiede direttamente 162.235 azioni ordinarie NMTC.
  • Titoli derivati: Nessuno segnalato.

La dichiarazione rappresenta una normale trattenuta fiscale sulle azioni e non indica acquisti o vendite sul mercato aperto. L'entità�<1% delle azioni detenute dall'esecutivo—� troppo piccola per influenzare significativamente la struttura proprietaria o indicare un cambiamento strategico.

El formulario 4 presentado para NeuroOne Medical Technologies Corp. (NMTC) revela una pequeña transacción interna realizada por el Director de Tecnología Steve Mertens el 30 de junio de 2025.

  • Tipo de transacción: Código F, que refleja acciones retenidas para cumplir con obligaciones fiscales.
  • Acciones afectadas: 906 acciones comunes a un precio indicado de $0.678 por acción.
  • Participación después de la transacción: Mertens posee directamente 162,235 acciones comunes de NMTC.
  • Valores derivados: No se reportan.

La presentación representa una retención rutinaria de acciones relacionada con impuestos y no indica compra o venta en el mercado abierto. La magnitud�<1% de las participaciones reportadas del ejecutivo—es demasiado pequeña para afectar materialmente la estructura de propiedad o señalar un cambio estratégico.

NeuroOne Medical Technologies Corp. (NMTC)ì—� 대í•� 제출ë� Form 4ëŠ� 최고기술책임ìž�(CTO) Steve Mertensê°¶Ä 2025ë…� 6ì›� 30ì�ì—� 수행í•� 소규ëª� ë‚´ë¶€ìž� 거래ë¥� 공개합니ë‹�.

  • 거래 유형: 코드 F, 세금 ì˜ë¬´ë¥� 충족하기 위해 주ì‹ì� ì›ì²œì§•수í•� 경우ë¥� 나타냅니ë‹�.
  • ì˜í–¥ì� ë°›ì€ ì£¼ì‹ ìˆ�: 주당 $0.678ì� ê°¶Ä격으ë¡� 906 보통ì£�.
  • 거래 í›� 보유 주ì‹: MertensëŠ� ì§ì ‘ 162,235 NMTC 보통주를 보유하고 있습니다.
  • íŒŒìƒ ì¦ê¶Œ: ì‹ ê³ ë� ë°� 없습니다.

ì´ë²ˆ ì‹ ê³ ëŠ� 세금 ê´€ë � ì£¼ì‹ ì›ì²œì§•수ì� ì¼í™˜ìœ¼ë¡œ, 공개 시장ì—서ì� 매매ë¥� ì˜ë¯¸í•˜ì§€ 않습니다. 규모갶Äâ€�ìž„ì› ë³´ìœ  주ì‹ì� <1%—너ë¬� 작아 소유 구조ì—� 중대í•� ì˜í–¥ì� 주거ë‚� ì „ëžµì � 변화를 시사하지 않습니다.

Le formulaire 4 déposé pour NeuroOne Medical Technologies Corp. (NMTC) révèle une transaction interne mineure effectuée par le directeur technique Steve Mertens le 30 juin 2025.

  • Type de transaction : Code F, indiquant des actions retenues pour satisfaire des obligations fiscales.
  • Actions concernées : 906 actions ordinaires au prix indiqué de 0,678 $ par action.
  • Participation après transaction : Mertens détient directement 162 235 actions ordinaires NMTC.
  • Valeurs dérivées : Aucune signalée.

Le dépôt représente une retenue d'actions liée aux impôts de routine et n'indique pas d'opérations d'achat ou de vente sur le marché libre. L'ampleur�<1 % des participations déclarées de l'exécutif—est trop faible pour affecter significativement la structure de propriété ou signaler un changement stratégique.

Das für NeuroOne Medical Technologies Corp. (NMTC) eingereichte Formular 4 offenbart eine geringfügige Insider-Transaktion des Chief Technology Officer Steve Mertens am 30. Juni 2025.

  • Transaktionstyp: Code F, was auf einbehaltene Aktien zur Erfüllung steuerlicher Verpflichtungen hinweist.
  • Betroffene Aktien: 906 Stammaktien zu einem angegebenen Preis von $0,678 pro Aktie.
  • Bestand nach der Transaktion: Mertens besitzt direkt 162.235 NMTC-Stammaktien.
  • Derivative Wertpapiere: Keine gemeldet.

Die Meldung stellt eine routinemäßige steuerbedingte Aktieneinbehaltung dar und weist nicht auf Käufe oder Verkäufe am offenen Markt hin. Das Ausmaß�<1% der gemeldeten Bestände des Geschäftsführers—ist zu gering, um die Eigentümerstruktur wesentlich zu beeinflussen oder auf eine strategische Änderung hinzuweisen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine tax-withholding of 906 shares; negligible ownership impact, neutral signal.

The Code F classification shows shares were surrendered to cover tax obligations tied to equity compensation rather than an elective sale. Mertens retains over 162 k shares, so insider alignment remains largely unchanged. Given the tiny volume and lack of market transaction, the Form 4 is informational but not valuation-relevant. I rate the market impact neutral.

Il modulo 4 presentato per NeuroOne Medical Technologies Corp. (NMTC) riporta una piccola transazione interna effettuata dal Chief Technology Officer Steve Mertens il 30 giugno 2025.

  • Tipo di transazione: Codice F, che indica azioni trattenute per soddisfare obblighi fiscali.
  • Azioni interessate: 906 azioni ordinarie a un prezzo indicato di $0,678 per azione.
  • Detenzione post-transazione: Mertens possiede direttamente 162.235 azioni ordinarie NMTC.
  • Titoli derivati: Nessuno segnalato.

La dichiarazione rappresenta una normale trattenuta fiscale sulle azioni e non indica acquisti o vendite sul mercato aperto. L'entità�<1% delle azioni detenute dall'esecutivo—� troppo piccola per influenzare significativamente la struttura proprietaria o indicare un cambiamento strategico.

El formulario 4 presentado para NeuroOne Medical Technologies Corp. (NMTC) revela una pequeña transacción interna realizada por el Director de Tecnología Steve Mertens el 30 de junio de 2025.

  • Tipo de transacción: Código F, que refleja acciones retenidas para cumplir con obligaciones fiscales.
  • Acciones afectadas: 906 acciones comunes a un precio indicado de $0.678 por acción.
  • Participación después de la transacción: Mertens posee directamente 162,235 acciones comunes de NMTC.
  • Valores derivados: No se reportan.

La presentación representa una retención rutinaria de acciones relacionada con impuestos y no indica compra o venta en el mercado abierto. La magnitud�<1% de las participaciones reportadas del ejecutivo—es demasiado pequeña para afectar materialmente la estructura de propiedad o señalar un cambio estratégico.

NeuroOne Medical Technologies Corp. (NMTC)ì—� 대í•� 제출ë� Form 4ëŠ� 최고기술책임ìž�(CTO) Steve Mertensê°¶Ä 2025ë…� 6ì›� 30ì�ì—� 수행í•� 소규ëª� ë‚´ë¶€ìž� 거래ë¥� 공개합니ë‹�.

  • 거래 유형: 코드 F, 세금 ì˜ë¬´ë¥� 충족하기 위해 주ì‹ì� ì›ì²œì§•수í•� 경우ë¥� 나타냅니ë‹�.
  • ì˜í–¥ì� ë°›ì€ ì£¼ì‹ ìˆ�: 주당 $0.678ì� ê°¶Ä격으ë¡� 906 보통ì£�.
  • 거래 í›� 보유 주ì‹: MertensëŠ� ì§ì ‘ 162,235 NMTC 보통주를 보유하고 있습니다.
  • íŒŒìƒ ì¦ê¶Œ: ì‹ ê³ ë� ë°� 없습니다.

ì´ë²ˆ ì‹ ê³ ëŠ� 세금 ê´€ë � ì£¼ì‹ ì›ì²œì§•수ì� ì¼í™˜ìœ¼ë¡œ, 공개 시장ì—서ì� 매매ë¥� ì˜ë¯¸í•˜ì§€ 않습니다. 규모갶Äâ€�ìž„ì› ë³´ìœ  주ì‹ì� <1%—너ë¬� 작아 소유 구조ì—� 중대í•� ì˜í–¥ì� 주거ë‚� ì „ëžµì � 변화를 시사하지 않습니다.

Le formulaire 4 déposé pour NeuroOne Medical Technologies Corp. (NMTC) révèle une transaction interne mineure effectuée par le directeur technique Steve Mertens le 30 juin 2025.

  • Type de transaction : Code F, indiquant des actions retenues pour satisfaire des obligations fiscales.
  • Actions concernées : 906 actions ordinaires au prix indiqué de 0,678 $ par action.
  • Participation après transaction : Mertens détient directement 162 235 actions ordinaires NMTC.
  • Valeurs dérivées : Aucune signalée.

Le dépôt représente une retenue d'actions liée aux impôts de routine et n'indique pas d'opérations d'achat ou de vente sur le marché libre. L'ampleur�<1 % des participations déclarées de l'exécutif—est trop faible pour affecter significativement la structure de propriété ou signaler un changement stratégique.

Das für NeuroOne Medical Technologies Corp. (NMTC) eingereichte Formular 4 offenbart eine geringfügige Insider-Transaktion des Chief Technology Officer Steve Mertens am 30. Juni 2025.

  • Transaktionstyp: Code F, was auf einbehaltene Aktien zur Erfüllung steuerlicher Verpflichtungen hinweist.
  • Betroffene Aktien: 906 Stammaktien zu einem angegebenen Preis von $0,678 pro Aktie.
  • Bestand nach der Transaktion: Mertens besitzt direkt 162.235 NMTC-Stammaktien.
  • Derivative Wertpapiere: Keine gemeldet.

Die Meldung stellt eine routinemäßige steuerbedingte Aktieneinbehaltung dar und weist nicht auf Käufe oder Verkäufe am offenen Markt hin. Das Ausmaß�<1% der gemeldeten Bestände des Geschäftsführers—ist zu gering, um die Eigentümerstruktur wesentlich zu beeinflussen oder auf eine strategische Änderung hinzuweisen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Linginfelter Henry P

(Last) (First) (Middle)
1 RIVERSIDE PLAZA

(Street)
COLUMBUS OH 43215

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AMERICAN ELECTRIC POWER CO INC [ AEP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock Units $0 06/30/2025 A 409.59 (1) (1) Common Stock 409.59 $103.76(2) 2,543.5 D
Explanation of Responses:
1. Stock Units are paid to the director in cash or shares upon termination of service unless the director has elected to defer payment for a period that results in payment commencing not later than five years thereafter.
2. Was AEP Stock Price at the time of the transaction.
Remarks:
/s/ David C. House, Attorney-in-Fact for Henry P. Linginfelter 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many NMTC shares did CTO Steve Mertens dispose of?

The filing shows 906 shares were withheld for taxes (Code F).

What is Steve Mertens� current NMTC shareholding after the transaction?

He directly owns 162,235 common shares.

Was this an open-market sale of NMTC stock?

No. Code F indicates shares were withheld by the company to cover tax liabilities, not sold on the market.

Were any NMTC derivative securities involved?

No derivative securities were reported in Table II of the Form 4.
Americn Electric

NASDAQ:AEP

AEP Rankings

AEP Latest News

AEP Latest SEC Filings

AEP Stock Data

55.48B
533.78M
0.03%
80.36%
1.81%
Utilities - Regulated Electric
Electric Services
United States
COLUMBUS